v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
3 Months Ended 185 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
OPERATING ACTIVITIES      
Net loss $ (713,732) $ (744,890) $ (49,571,686)
Depreciation     52,694
Stock-based compensation-product development costs 833 1,499 537,196
Stock-based compensation-interest expenses     13,330,984
Stock-based compensation-selling, general and administration   51,967 3,486,791
Stock-based compensation-professional fees   11,992 217,774
Stock-based compensation – market development     20,989
Non-cash imputed interest expenses (2,300) 48,478 3,348,764
Accrued interest on line of credit 170,627 95,884 1,403,571
Equity instruments issued to settle liabilities     1,871,718
Other non-cash items included in net loss     341,629
Changes in operating assets and liabilities:      
(Increase) decrease in prepaid expenses (6,981) 3,338 (11,369)
Increase (decrease) in accounts payable and accrued liabilities 41,040 42,232 1,611,203
Increase in interest payable 158,476 126,518 4,896,483
Increase in advances payable   5,000 3,152,071
Income tax receivable     8,727
Net cash used in operating activities (352,037) (357,982) (15,302,461)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Net cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Proceeds from borrowings on line of credit 323,215 361,769 5,843,585
Proceeds from issuance of promissory notes     9,418,676
Proceeds from issuance of shares     1,512,403
Repayment of promissory notes payable     (970,879)
Expenditures to repurchase shares     (342,038)
Other financing activities     (115,472)
Net cash provided by financing activities 323,215 361,769 15,346,275
Change in cash (28,822) 3,787 736
Cash, beginning of period 29,558 11,082  
Cash, end of period 736 14,869 736
Shares issued to settle liabilities   $ 30,000